Document is current
Any future updates will be listed below
-
Authors
Cuyàs, Elisabet https://orcid.org/0000-0001-5353-440X
Pedarra, Stefano
Verdura, Sara
Pardo, Miguel Angel https://orcid.org/0000-0003-4823-6613
Espin Garcia, Roderic https://orcid.org/0000-0003-2494-0964
Serrano-Hervás, Eila https://orcid.org/0000-0002-9477-0350
Llop-Hernández, Àngela
Teixidor, Eduard
Bosch-Barrera, Joaquim https://orcid.org/0000-0002-0893-7821
López-Bonet, Eugeni
Martin-Castillo, Begoña
Lupu, Ruth https://orcid.org/0000-0002-5564-3172
Pujana, Miguel Angel https://orcid.org/0000-0003-3222-4044
Sardanyès, Josep https://orcid.org/0000-0001-7225-5158
Alarcón, Tomás
Menendez, Javier A. https://orcid.org/0000-0001-8733-4561
- License Information
-
More Information
Article History
Received: 4 July 2024
Revised: 16 September 2024
Accepted: 18 September 2024
First Online: 30 September 2024
Competing interests
: Joaquim Bosch-Barrera reports grant funding and personal fees from Pfizer, MSD Spain, BMS, AstraZeneca, Novartis, Boehringer-Ingelheim, Vifor, Sanofi, and LEO Pharma outside the submitted work. These companies had no role in the design of the study, in the collection, analysis, or interpretation of the data; in writing the manuscript; or in the decision to submit the results for publication. All of the other authors declare that they have no known competing financial interests or personal relationships that could potentially influence the work reported in this article.
: All authors agreed to the publication of the article. All data were in-house and no paper mills were used. To ensure integrity and accuracy, all authors agree to take responsibility for all aspects of the work. The authors did not use any AI tool/service or AI-enabled technologies in the preparation of this paper.
